These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 6209989

  • 41. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF, Mohs RC, Davis KL.
    Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
    [Abstract] [Full Text] [Related]

  • 42. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
    Agren H.
    Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
    [Abstract] [Full Text] [Related]

  • 43. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.
    Wieselgren IM, Lindström LH.
    Psychiatry Res; 1998 Nov 16; 81(2):101-10. PubMed ID: 9858027
    [Abstract] [Full Text] [Related]

  • 44. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts.
    Banki CM, Vojnik M, Papp Z, Balla KZ, Arató M.
    Biol Psychiatry; 1985 Feb 16; 20(2):163-71. PubMed ID: 2578829
    [Abstract] [Full Text] [Related]

  • 45. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 16; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 46. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.
    Lundmark J, Wålinder J, Alling C, Manniche PM, Dalgaard L.
    Eur Neuropsychopharmacol; 1994 Mar 16; 4(1):1-6. PubMed ID: 7515737
    [Abstract] [Full Text] [Related]

  • 47. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ, Walsh FX, Bird ED, Levy HL.
    Pediatrics; 1985 Mar 16; 75(3):580-6. PubMed ID: 2579365
    [Abstract] [Full Text] [Related]

  • 48. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
    Fyrö B, Petterson U, Sedvall G.
    Psychopharmacologia; 1975 Oct 14; 44(1):99-103. PubMed ID: 1105629
    [Abstract] [Full Text] [Related]

  • 49. Cerebrospinal fluid amine metabolites in acute schizophrenia.
    Post RM, Fink E, Carpenter WT, Goodwin FK.
    Arch Gen Psychiatry; 1975 Aug 14; 32(8):1063-9. PubMed ID: 1156113
    [Abstract] [Full Text] [Related]

  • 50. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 14; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 51. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide.
    Jones JS, Stanley B, Mann JJ, Frances AJ, Guido JR, Traskman-Bendz L, Winchel R, Brown RP, Stanley M.
    Am J Psychiatry; 1990 Sep 14; 147(9):1225-7. PubMed ID: 1696794
    [Abstract] [Full Text] [Related]

  • 52. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
    Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS.
    Neuropsychopharmacology; 2001 Oct 14; 25(4):468-75. PubMed ID: 11557160
    [Abstract] [Full Text] [Related]

  • 53. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 54. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun 12; 24(3):130-2, 186. PubMed ID: 1716195
    [Abstract] [Full Text] [Related]

  • 55. MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia.
    Faustman WO, King RJ, Faull KF, Moses JA, Benson KL, Zarcone VP, Csernansky JG.
    J Affect Disord; 1991 Aug 12; 22(4):235-9. PubMed ID: 1939932
    [Abstract] [Full Text] [Related]

  • 56. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
    Kishida I, Aklillu E, Kawanishi C, Bertilsson L, Agren H.
    Neuropsychopharmacology; 2007 Oct 12; 32(10):2143-51. PubMed ID: 17299512
    [Abstract] [Full Text] [Related]

  • 57. Acid metabolites and precursor amino acids of 5-hydroxytryptamine and dopamine in affective and other psychiatric disorders.
    Korf J, van den Burg W, van den Hoofdakker RH.
    Psychiatr Clin (Basel); 1983 Oct 12; 16(1):1-16. PubMed ID: 6189146
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
    Maas JW, Kocsis JH, Bowden CL, Davis JM, Redmond DE, Hanin I, Robins E.
    Psychol Med; 1982 Feb 12; 12(1):37-43. PubMed ID: 6177015
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.